Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
<p>Modifications to vaccine delivery that increase serum antibody longevity are of great interest for maximizing efficacy. We have previously shown that a delayed fractional (DFx) dosing schedule (0-1-6 month) — using AS01<sub>B</sub>-adjuvanted RH5.1 malaria antigen &...
Asıl Yazarlar: | Nielsen, CM, Barrett, JR, Davis, C, Fallon, JK, Goh, C, Michell, AR, Griffin, C, Kwok, A, Loos, C, Darko, S, Laboune, F, Tekman, M, Diouf, A, Miura, K, Francica, JR, Ransier, A, Long, CA, Silk, SE, Payne, RO, Minassian, AM, Lauffenburger, DA, Seder, RA, Douek, DC, Alter, G, Draper, SJ |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
2023
|
Benzer Materyaller
-
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Yazar:: Carolyn M. Nielsen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01) -
Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
Yazar:: Minassian, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
Yazar:: Miura, K, ve diğerleri
Baskı/Yayın Bilgisi: (2023) -
HLA-B51 IN BEHÇET’S DISEASE
Yazar:: F Davatchi, ve diğerleri
Baskı/Yayın Bilgisi: (2008-12-01) -
HLA-B51 IN BEHÇET’S DISEASE
Yazar:: F Davatchi, ve diğerleri
Baskı/Yayın Bilgisi: (2008-12-01)